INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹193 Cr | ₹342 Cr | ₹389 Cr | ₹349 Cr | ₹216 Cr |
What is the latest Net Current Assets ratio of INDOCO REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹193 Cr |
| Mar2024 | ₹342 Cr |
| Mar2023 | ₹389 Cr |
| Mar2022 | ₹349 Cr |
| Mar2021 | ₹216 Cr |
How is Net Current Assets of INDOCO REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹193 Cr | -43.52 | |
| Mar2024 | ₹342 Cr | -12.01 | |
| Mar2023 | ₹389 Cr | 11.55 | |
| Mar2022 | ₹349 Cr | 61.76 | |
| Mar2021 | ₹216 Cr | - | |
Compare Net Current Assets of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,753.7 Cr | 9.4% | -5.5% | -19.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 9.4% |
-5.5% |
-19.2% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses